Literature DB >> 5064903

15-hydroxy-9-oxoprosta-11, 13-dienoic acid as the product of a prostaglandin isomerase.

R L Jones.   

Abstract

The initial product of the interaction between prostaglandin A(1) and the prostaglandin isomerase of cat blood plasma has been isolated. By ultraviolet spectroscopy and mass spectrometry and from stability and chromatographic studies, the structure of the compound has been established as 15-hydroxy-9-oxoprosta-11,13-dienoic acid, an allylic isomer of prostaglandin A(1). The compound is unstable under mild alkaline conditions, isomerizing to prostaglandin B(1). The biological significance of the enzymatic isomerization of prostaglandin A(1) is discussed.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5064903

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  6 in total

1.  Proceedings: The identification of individual prostaglandins using a LKB 9000 gas chromatograph-mass spectrometer.

Authors:  N L Poyser; E W Horton
Journal:  Br J Pharmacol       Date:  1974-09       Impact factor: 8.739

2.  Cardiovascular actions of prostaglandin C in the cat and dog.

Authors:  R L Jones; K A Kane; A Ungar
Journal:  Br J Pharmacol       Date:  1974-06       Impact factor: 8.739

3.  Output of prostaglandins from the rabbit kidney, its increase on renal nerve stimulation and its inhibition by indomethacin.

Authors:  H A Davis; E W Horton
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

4.  Pathways of prostaglandin F2alpha metabolism in mammalian kidneys.

Authors:  J R Hoult; P K Moore
Journal:  Br J Pharmacol       Date:  1977-12       Impact factor: 8.739

5.  Inhibitors of rabbit plasma prostaglandin A isomerase.

Authors:  R L Jones
Journal:  Biochem J       Date:  1974-05       Impact factor: 3.857

6.  Analysis of eicosanoid oxidation products in Alzheimer brain by LC-MS with uniformly 13C-labeled internal standards.

Authors:  Ran Furman; Jin V Lee; Paul H Axelsen
Journal:  Free Radic Biol Med       Date:  2018-02-21       Impact factor: 7.376

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.